# Flex Biomedical, Inc.: Form D filings

Flex Biomedical, Inc., a pharmaceuticals company in Madison, WI, filed 3 Form D notices with the SEC between 2009 and 2012. The latest, on June 20, 2012, reports $881,668 sold of a $1 million offering to 13 investors.

Find out what Flex Biomedical, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Flex%20Biomedical%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Flex%20Biomedical%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fflex-biomedical-inc-1465854)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Flex%20Biomedical%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Flex%20Biomedical%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fflex-biomedical-inc-1465854)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Wisconsin](https://specstream.ai/data/form-d/state/wisconsin): 361 rows, by operating companies, filed since November 1, 2024, $18.05, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/wisconsin
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 555 D'ONOFRIO DRIVE, SUITE 102, Madison, WI, 53719
- Phone: (608) 213-8246
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2007
- Revenue range: No Revenues
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1465854

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jun 20, 2012 | New notice | $1,000,000 | $881,668 | $118,332 | 13 | Jun 4, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1465854/000146585412000003/0001465854-12-000003-index.htm) |
| Nov 3, 2010 | New notice | $694,101 | $694,101 | $0 | 8 | Oct 19, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1465854/000146585410000002/0001465854-10-000002-index.htm) |
| Jun 15, 2009 | New notice | $1,250,000 | $812,000 | $438,000 | 8 | Jun 10, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1465854/000146585409000001/0001465854-09-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Hideki C. Suzuki, PhD | Executive Officer |  |
| Salvatore P. Braico | Executive Officer, Director |  |
| Nicholas E. Mischler, MD | Director |  |
| Mark P. Grinstaff | Director |  |
| Donald R. Urbanowicz | Director |  |
| David C. Sneider | Director |  |
| Steven R. Pollock, RPh, MBA | Director |  |
| Michael C. Wathier, PhD | Executive Officer |  |

[Every Form D from the week of Jun 18, 2012](https://specstream.ai/data/form-d/week/2012-06-18) · [All recent filings in Wisconsin](https://specstream.ai/data/form-d/state/wisconsin) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Flex Biomedical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).